Estrogen modulates neuronal Bcl-x(L) expression and β-amyloid-induced apoptosis: Relevance to Alzheimer's disease

Journal of Neurochemistry

Volumn 72, Issue 4, 1999, Pages 1552-1563

  Pike, Christian J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid; Alzheimer's disease; Apoptosis; Bcl x(L); Estrogen; Neuroprotection

Indexed keywords

AMYLOID BETA PROTEIN; ESTROGEN; PROTEIN BCL X;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; EMBRYO; ESTROGEN ACTIVITY; HIPPOCAMPUS; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; RAT; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES; APOPTOSIS; BCL-X PROTEIN; BRAIN CHEMISTRY; CASPASES; CELLS, CULTURED; ESTRADIOL; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; IMMUNITY, NATURAL; MALE; MIDDLE AGED; NEURONS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN;

ANIMALIA;

EID: 0032997908     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.721552.x     Document Type: Article

References (84)

1. Arimatsu Y. and Hatanaka H. (1986) Estrogen treatment enhances survival of cultured fetal rat amygdala neurons in a defined medium. Dev. Brain Res. 26, 151-159.
2. Bachman D. L., Wolf P. A., Linn R., Knoefel J. E., Cobb J., Belanger A., D'Agostino R. B., and White L. R. (1992) Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study. Neurology 42, 115-119.
3. Behl C., Widmann M., Trapp T., and Holsboer F. (1995) 17-β Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473-482.
4. Behl C., Skutella T., Lezouale'h F., Post A., Widmann M., Newton C. J., and Holsboer F. (1997) Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51, 535-541.
5. Berry M., Nunez A. M., and Chambon P. (1989) Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. Proc. Natl. Acad. Sci. USA 86, 1218-1222.
6. Bettini E., Pollio G., Santagati S., and Maggi A. (1992) Estrogen receptor in rat brain: presence in the hippocampal formation. Neuroendocrinology 56, 502-508.
7. Bhargava V., Kell D. L., van de Rijn M., and Warnke R. A. (1994) Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am. J. Pathol. 145, 535-540.
8. Birge S. J. (1997) The role of estrogen in the treatment of Alzheimer's disease. Neurology 48, S36-S41.
9. Blaustein J. D. (1993) Estrogen receptor immunoreactivity in rat brain: rapid effects of estradiol injection. Endocrinology 132, 1218-1224.
10. Boise L. H., Gonzalez-Garcia M., Postema C. E., Ding L., Lindsten T., Turka L. A., Mao X., Nunez G., and Thompson C. B. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608.
11. Brenner D. E., Kukull W. A., Stergachis A., van Belle G., Bowen J. D., McCormick W. C., Teri L., and Larson E. B. (1994) Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am. J. Epidemiol. 140, 262-267.
12. Buckwalter J. G., Sobel E., Dunn M. E., Diz M. M., and Henderson V. W. (1993) Gender differences on a brief measure of cognitive functioning in Alzheimer's disease. Arch. Neurol. 50, 757-760.
13. Busciglio J., Yeh J., and Yankner B. A. (1993) β-Amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J. Neurochem. 61, 1565-1568.
14. Carson J., Schrader W. T., and O'Malley B. W. (1990) Steroid receptor family: structure and functions. Endocr. Rev. 11, 201-220.
15. 1 function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271, 4573-4576.
16. Cotman C. W. and Anderson A. J. (1995) A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol. Neurobiol. 10, 19-45.
17. Cummings B. J., Pike C. J., Shankle S., and Cotman C. W. (1996) β-Amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging 17, 921-933.
18. Doglioni C., Dei T. A., Laurino L., Chiarelli C., Barbareschi M., and Viale G. (1994) The prevalence of BCL-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch. 424, 47-51.
19. Doraiswamy P. M., Bieber F., Kaiser L., Krishnan K. R., Reuning S. J., and Gulanski B. (1997) The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials. Neurology 48, 1511-1517.
20. Eppenberger U., Wosikowski K., and Kung W. (1991) Pharmacologic and biologic properties of droloxifene, a new antiestrogen. Am. J. Clin. Oncol. 14 (Suppl. 2), S5-S14.
21. Faivre-Bauman A., Rosenbaum E., Puymirat J., Grouselle D., and Tixier-Vidal A. (1981) Differentiation of fetal mouse hypothalamic cells in serum-free medium Dev. Neurosci. 4, 118-129.
22. Fillit H., Weinreb H., Cholst I., Luine V., McEwen B., Amador R., and Zabriskie J. (1986) Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 11, 337-345.
23. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., and Angeretti N. (1993) Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25-35. Neuroreport 4, 523-526.
24. Garcia-Segura L. M., Cardon P., Naftolin F., and Chowen J. A. (1998) Estradiol upregulates bcl-2 expression in adult brain neurons. Neuroreport 9, 593-597.
25. Gompel A., Sabourin J. C., Martin A., Yaneva H., Audouin J., Decroix Y., and Poitout P. (1994) Bcl-2 expression in normal endometrium during the menstrual cycle. Am. J. Pathol. 144, 1195-1202.
26. Gonzalez-Garcia M., Garcia I., Ding L., O'Shea S., Boise L. H., Thompson C. B., and Nuñez G. (1995) bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc. Natl. Acad. Sci. USA 92, 4304-4308.
27. Goodman Y., Bruce A. J., Cheng B., and Mattson M. P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity. oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844.
28. Green P. S., Bishop J., and Simpkins J. W. (1997) 17-α-Estradiol exerts neuroprotective effects on SK-N-SH cells. J. Neurosci. 17, 511-515.
29. Greenberg S. G. and Davies P. (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc. Natl. Acad. Sci. USA 87, 5827-5831.
30. Grillot D. A. M., González-García M., Ekhterae D., Duan L., Inohara N., Ohta S., Seidin M. F., and Nunez G. (1997) Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J. Immunol. 158, 4750-4757.
31. Henderson V. W. (1997) The epidemiology of estrogen replacement therapy and Alzheimer's disease. Neurology 48, S27-S35.
32. Henderson V. W. and Buckwalter J. G. (1994) Cognitive deficits of men and women with Alzheimer's disease. Neurology 44, 90-96.
33. Henderson V. W., Paganini H. A., Emanuel C. K., Dunn M. E., and Buckwalter J. G. (1994) Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch. Neurol. 51, 896-900.
34. Honjo H., Ogino Y., Naitoh K., Urabe M., Kitawaki J., Yasuda J., Yamamoto T., Ishihara S., Okada H., Yonezawa T., Hayashi K., and Nambara T. (1989) In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type). J. Steroid Biochem. 34, 521-525.
35. Huang Y., Ray S., Reed J. C., Ibrado A. M., Tang C., Nawabi A., and Bhalla K. (1997) Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res. Treat. 42, 73-81.
36. Hyder S. M., Stancel G. M., Nawaz Z., McDonnell D. P., and Loose-Mitchell D. S. (1992) Identification of an estrogen response element in the 3'-flanking region of the murine c-fos protooncogene. J. Biol. Chem. 267, 18047-18054.
37. Kaiser F. E. and Morley J. E. (1995) Reproductive hormonal changes in the aging male, in Hormones and Aging (Timiras P. S., Quay W. B., and Vernadakis A., eds), pp. 153-166. CRC Press, Boca Raton, Florida.
38. Kandouz M., Siromachkova M., Jacob D., Chretien Marquet B., Thenvath A., and Gompel A. (1996) Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells. Int. J. Cancer 68, 120-125.
39. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D. D., and Metter E. (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48, 1517-1521.
40. +-ATPase activity, glucose transport, and glutamate transport induced by amyloid β-peptide and iron. J. Neurosci. Res. 50, 522-530.
41. Klein-Hitpass L., Ryffel G. U., Heitlinger E., and Cato A. C. (1988) A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucleic Acids Res. 16, 647-663.
42. Koh J.-Y., Yang L. L., and Cotman C. W. (1990) β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533, 315-320.
43. Krajewski S., Krajewska M., Shabaik A., Wang H. G., Irie S., Fong L., and Reed J. C. (1994) Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res. 54, 5501-5507.
44. Kumar V. and Chambon P. (1988) The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55, 145-156.
45. Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J., and Cotman C. W. (1993) Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA 90, 7951-7955.
46. Lorenzo A. and Yankner B. A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA 91, 12243-12247.
47. Maggi A., Susanna L., Bettini E., Mantero G., and Zucchi I. (1989) Hippocampus: a target for estrogen action in mammalian brain. Mol. Endocrinol. 3, 1165-1170.
48. Mashima T., Naito M., Noguchi K., Miller D. K., Nicholson D. W., and Tsuruo T. (1997) Actin cleavage by CPP-32/apopain during the development of apoptosis. Oncogene 14, 1007-1012.
49. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., and Rydel R. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376-389.
50. Mattson M. P., Robinson N., and Guo Q. (1997) Estrogens stabilize mitochondrial function and protect neural cells against the proapoptotic action of mutant presenilin-1. Neuroreport 8, 3817-3821.
51. McEwen B. S., Alves S. E., Bulloch K., and Weiland N. G. (1997) Ovarian steroids and the brain: implications for cognition and aging. Neurology 48 (Suppl. 7), S8-S15.
52. Mizuguchi M., Sohma O., Takashima S., Ikeda K., Yamada M., Shiraiwa N., and Ohta S. (1996) Immunochemical and immunohistochemical localization of Bcl-x protein in the rat central nervous system. Brain Res. 712, 281-286.
53. Mook-Jung I., Joo I., Sohn S., Kwon H. J., Huh K., and Jung M. W. (1997) Estrogen blocks neurotoxic effects of β-amyloid (1-42) and induces neurite extension on B103 cells. Neurosci. Lett. 235, 101-104.
54. Mooradian A. D. (1993) Antioxidant properties of steroids. J. Steroid Biochem. Mol. Biol. 45, 509-511.
55. Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., and Hagino N. (1994) Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr. J. 41, 361-371.
56. O'Keefe J. A., Li Y., Burgess L. H., and Handa R. J. (1995) Estrogen receptor mRNA alterations in the developing rat hippocampus. Mol. Brain Res. 30, 115-124.
57. Otsuki Y., Misaki O., Sugimoto O., Ito Y., Tsujimoto Y., and Akao Y. (1994) Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle. Lancet 344, 28-29.
58. Paganini-Hill A. and Henderson V. W. (1994) Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140, 256-261.
59. Pike C. J. and Cotman C. W. (1993) Cultured GABA-immunoreactive neurons are resistant to toxicity induced by β-amyloid. Neuroscience 56, 269-274.
60. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
61. Pike C. J., Cummings B. J., Monzavi R., and Cotman C. W. (1994) β-Amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience 63, 517-531.
62. Pike C. J., Cummings B. J., and Cotman D. W. (1995a) Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp. Neurol. 132, 172-179.
63. Pike C. J., Walencewicz-Wasserman A. J., Kosmoski J., Cribbs D. H., Glabe C. G., and Cotman C. W. (1995b) Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253-265.
64. Pike C. J., Vaughan P. J., Cunningham D. D., and Cotman C. W. (1996) Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by β-amyloid in vitro. J. Neurochem. 66, 1374-1382.
65. Pike C. J., Ramezan-Arab N., and Cotman C. W. (1997) β-Amyloid neurotoxicity in vitro: evidence of oxidative stress by not protection by antioxidants. J. Neurochem. 69, 1601-1611.
66. Register T. C., Shively C. A., and Lewis C. E. (1998) Expression of estrogen receptor α and βtranscripts in female monkey hippocampus and hypothalamus. Brain Res. 788, 320-322.
67. Schneider L. S., Farlow M. R., Henderson V. W., and Pogoda J. M. (1996) Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 46, 1580-1584.
68. Shi S.-R., Gu J., Kalra K. L., Chen T., Cote R. J., and Taylor C. R. (1995) Antigen retrieval technique: a novel approach to immunohistochemistry on routinely processed tissue sections Cell Vis. 2, 6-22.
69. Simerly R. B., Chang C., Muramatsu M., and Swanson L. W. (1990) Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol. 294, 76-95.
70. Singer C. A., Rogers K. L., Strickland T. M., and Dorsa D. M. (1996) Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 212, 13-16.
71. Srinivasan A., Foster L. M., Testa M. P., Ord T., Keane R. W., Bredesen D. E., and Kayalar C. (1996) Bcl-2 expression in neural cells blocks activation of ICE/CED-3 family proteases during apoptosis. J. Neurosci. 16, 5654-5660.
72. Tang M. X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., and Mayeux R. (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432.
73. Teixeira C., Reed J. C., and Pratt M. A. (1995) Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55, 3902-3907.
74. Tohgi H., Utsugisawa K., Yamagata M., and Yoshimura M. (1995) Effects of age on messenger RNA expression of glucocorticoid, thyroid hormone, androgen, and estrogen receptors in postmortem human hippocampus. Brain Res. 700, 245-253.
75. Tomiyama T., Shoji A., Kataoka K., Suwa Y., Asano S., Kaneko H., and Endo N. (1996) Inhibition of amyloid β protein aggregation and neurotoxicity by rifampicin. J. Dial. Chem. 271, 6839-6844.
76. Villa P., Kaufman S. H., and Earnshaw W. C. (1997) Caspases and caspase inhibitors. Trends Biochem. Sci. 22, 388-393.
77. Wang T. T. Y. and Phang J. M. (1995) Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res. 55, 2487-2489.
78. Weaver C. E. Jr., Park C. M., Gibbs T. T., and Farb D. H. (1997) 17β-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 761, 338-341.
79. Weiland N. G., Orikasa C., Hayashi S., and McEwen B. S. (1997) Distribution and hormone regulation of estrogen receptor immunoreactive cells in the hippocampus of male and female rats. J. Comp. Neurol 388, 603-612.
80. Yachnis A. T., Powell S. Z., Olmsted J. J., and Eskin T. A. (1997) Distinct neurodevelopmental patterns of bcl-2 and bcl-x expression are altered in glioneuronal hamartias of the human temporal lobe. J. Neuropathol. Exp. Neurol. 56, 186-198.
81. Yang F., Sun X., Beech W., Teter B., Wu S., Sigel J., Vinters H., Frautschy S. A., and Cole G. M. (1998) Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque associated neurons and microglia in Alzheimer's disease. Am. J. Pathol. 152, 379-389.
82. Yankner B. A. (1996) Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
83. Zhang M. Y., Katzman R., Salmon D., Jin H., Cai G. J., Wang Z. Y., Qu G. Y., Grant I., Yu E., and Levy P. (1990) The prevalence of dementia and Alzheimer's disease in Shanghai. China: impact of age, gender, and education. Ann. Neurol. 27, 428-437.
84. 2 generation. J. Neurochem. 67, 1595-1606.